Market for Prophylactic Medicaments Containing Insulin in Iraq
The size of the prophylactic medicaments containing insulin market in Iraq surged to $ in , growing by % against the previous year. This figure reflects the total revenues of producers and importers (excluding logistics costs, retail marketing costs, and retailers' margins, which will be included in the final consumer price). Overall, consumption showed a mild increase. Prophylactic medicaments containing insulin consumption peaked at $ in 2018; however, from 2019 to , consumption failed to regain momentum.